---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-037425"
form_type: "8-K/A"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:28:45.198143+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Indivior assigns new director Kingsley to Audit & Risk and Compensation committees

## Summary
- Stuart A. (Tony) Kingsley appointed non-executive director effective July 1, 2025.
- He will serve on the Audit & Risk Committee and the Compensation Committee.
- Appointment previously disclosed; amendment adds committee assignment details.

## SEC filing metadata
- accession: 0001628280-25-037425
- form_type: 8-K/A
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000162828025037425/0001628280-25-037425-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000162828025037425/indv-20250620.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-037425
- JSON: https://secwatch.observer/filing/0001628280-25-037425.json
- Plain text: https://secwatch.observer/filing/0001628280-25-037425.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.